Global Nanobiotechnology Market to Reach $160.3 Billion by 2030

NEW YORK, March 10, 2023 /PRNewswire/ — The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Read the full report: https://www.reportlinker.com/p04707106/?utm_source=PRN

Global Nanobiotechnology Market to Reach $160.3 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Nanobiotechnology estimated at US$104.8 Billion in the year 2022, is projected to reach a revised size of US$160.3 Billion by 2030, growing at aCAGR of 5.5% over the period 2022-2030. Pharmaceuticals & Biotechnology Industry, one of the segments analyzed in the report, is projected to record 6.3% CAGR and reach US$110.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Medical Devices segment is readjusted to a revised 3.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $30.6 Billion, While China is Forecast to Grow at 4.8% CAGR

The Nanobiotechnology market in the U.S. is estimated at US$30.6 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$27.6 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 3.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Select Competitors (Total 79 Featured)

– Ablynx NV

– Arrowhead Pharmaceuticals Inc.

– CaPtivate Pharmaceuticals LLC

– Celgene Corporation

– ELITechGroup

– Flamel Technologies SA

– GlaxoSmithKline Plc

– Johnson & Johnson

– Merck & Co. Inc.

– NanoBio® Corporation

– Nanophase Technologies Corporation

– pSivida Corp.

– Sigma-Aldrich Corp.

– Starpharma Holdings Ltd.

– Vectura Group plc

Read the full report: https://www.reportlinker.com/p04707106/?utm_source=PRN

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights

World Market Trajectories

A Curtain Raiser

Recent Market Activity

Nanobiotechnology – The Next Big Thing

An Insight into the Global Nanobiotechnology Market

Major Market Drivers

Where Conventional Molecular Science Falls Short Nanobio Steps In

Nanotechnology Revolutionizes Pharmaceuticals & Healthcare Sector

Nanomedicine Market to Achieve Phenomenal Growth

Opportunities Galore for Nanomedicine

Drug Delivery – A Promising Application Area for Nanotechnology

Nanotechnology Offers Huge Potential in Brain Disorder Treatment

High Demand for Nanobots and Nano Healthcare Devices

Nanotechnology Gaining Prominence for Treatment of Cancer

Nanotechnology in Drug Delivery: A Specialized Market Opportunity

Commercialization of Nanotechnology-based Medical Products

Gains Momentum

Nanodiagnostic Products to Witness Strong Demand Growth

Dendrimers Serve as a Base to Build Multifunctional Nanodevices

Nanotechnology Rescues Poor Water Soluble Drugs from Abandonment

Huge Opportunities for Nanomaterials in the Medical Field

Commercial Opportunities in Healthcare Sector

Future Possibilities

Global Market for Fullerenes – An Insight

Dawn Breaks on Nanobiotechnology

Demystifying the Intriguing World of Nanobiotech

A Meeting Place of Medicine?s Best Solutions

Nanobiotechnology to Become Viable for All Drug Development Stages

Nanoparticles: The Foundation of Nanobiotechnology

Improved Optical Properties and Stability of Nanoparticles

Nanoemulsions

The Promise of Nanobiotechnology

Biological Weaponries against Diseases Come in Small Packages

Proffered Benefits of Nanobiotechnology

Opportunity & Beyond

Nanobiotechnology – Will it Live Up to the Expectations?

The Future of Nanobiotechnology: Shape of Things to Come

Nanobiotechnology: The Outer Limits

Futuristics: A Rumination

Conclusions

Nanobiotechnology – Global Key Competitors Percentage Market

Share in 2022 (E)

Impact of Covid-19 and a Looming Global Recession

Competitive Market Presence – Strong/Active/Niche/Trivial for

Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

Ablynx NV (Belgium)

Arrowhead Pharmaceuticals, Inc. (USA)

Avadel Pharmaceuticals plc (Ireland)

CaPtivate Pharmaceuticals LLC (USA)

Celgene Corporation (USA)

ELITechGroup (France)

GlaxoSmithKline Plc. (UK)

Johnson & Johnson (USA)

Merck & Co., Inc. (USA)

NanoBio® Corporation (USA)

Nanophase Technologies Corporation (USA)

pSivida Corp. (USA)

Sigma-Aldrich Corp. (USA)

Starpharma Holdings Ltd. (Australia)

Vectura Group plc (UK)

3. MARKET TRENDS & DRIVERS

Present Status and Future Opportunities

Outlook

Developing Countries to Rise over the Horizon

Nanomaterials & Nanoparticles Witness Robust Activity

Focus on Improved Performance to Bring New Manufacturing

Methods for Nanomaterials

Why Invest in Nanobiotechnology?

Private and Public Companies to Step Up Funding on Nanotechnology

United States Lead the Way in Government Funding

Increasing Awareness on Technology to Drive Growth

Demand for Novel Products to Push Up Growth

Nano-Enabled Drug Discovery Holds Tremendous Potential

Consolidation Sharpens the Industry’s Edge

The Regulatory Framework Evolves with the Technology

Quantum Dot Patents Pose Legal Tangles

Miniaturized Liquid Handling Becomes Progressive

Trends in Nanotechnology Enabled Drug Delivery Systems

Patent Expiries: A Key Driver

Nanotechnology Enabled Drug Delivery to Exhume Unused Drugs

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for

Nanobiotechnology by Geographic Region – USA, Canada, Japan,

China, Europe, Asia-Pacific and Rest of World Markets –

Independent Analysis of Annual Sales in US$ Million for Years

2022 through 2030 and % CAGR

Table 2: World Historic Review for Nanobiotechnology by

Geographic Region – USA, Canada, Japan, China, Europe,

Asia-Pacific and Rest of World Markets – Independent Analysis

of Annual Sales in US$ Million for Years 2014 through 2021 and

% CAGR

Table 3: World 16-Year Perspective for Nanobiotechnology by

Geographic Region – Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of

World Markets for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for

Pharmaceuticals & Biotechnology Industry by Geographic Region –

USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of

World Markets – Independent Analysis of Annual Sales in US$

Million for Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for Pharmaceuticals &

Biotechnology Industry by Geographic Region – USA, Canada,

Japan, China, Europe, Asia-Pacific and Rest of World Markets –

Independent Analysis of Annual Sales in US$ Million for Years

2014 through 2021 and % CAGR

Table 6: World 16-Year Perspective for Pharmaceuticals &

Biotechnology Industry by Geographic Region – Percentage

Breakdown of Value Sales for USA, Canada, Japan, China, Europe,

Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for

Medical Devices by Geographic Region – USA, Canada, Japan,

China, Europe, Asia-Pacific and Rest of World Markets –

Independent Analysis of Annual Sales in US$ Million for Years

2022 through 2030 and % CAGR

Table 8: World Historic Review for Medical Devices by

Geographic Region – USA, Canada, Japan, China, Europe,

Asia-Pacific and Rest of World Markets – Independent Analysis

of Annual Sales in US$ Million for Years 2014 through 2021 and

% CAGR

Table 9: World 16-Year Perspective for Medical Devices by

Geographic Region – Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of

World for Years 2014, 2023 & 2030

Table 10: World Nanobiotechnology Market Analysis of Annual

Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES

Nanobiotechnology Market Presence – Strong/Active/Niche/Trivial –

Key Competitors in the United States for 2023 (E)

Table 11: USA Recent Past, Current & Future Analysis for

Nanobiotechnology by End-Use – Pharmaceuticals & Biotechnology

Industry and Medical Devices – Independent Analysis of Annual

Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 12: USA Historic Review for Nanobiotechnology by End-Use –

Pharmaceuticals & Biotechnology Industry and Medical Devices

Markets – Independent Analysis of Annual Sales in US$ Million

for Years 2014 through 2021 and % CAGR

Table 13: USA 16-Year Perspective for Nanobiotechnology by

End-Use – Percentage Breakdown of Value Sales for

Pharmaceuticals & Biotechnology Industry and Medical Devices

for the Years 2014, 2023 & 2030

CANADA

Table 14: Canada Recent Past, Current & Future Analysis for

Nanobiotechnology by End-Use – Pharmaceuticals & Biotechnology

Industry and Medical Devices – Independent Analysis of Annual

Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 15: Canada Historic Review for Nanobiotechnology by

End-Use – Pharmaceuticals & Biotechnology Industry and Medical

Devices Markets – Independent Analysis of Annual Sales in US$

Million for Years 2014 through 2021 and % CAGR

Table 16: Canada 16-Year Perspective for Nanobiotechnology by

End-Use – Percentage Breakdown of Value Sales for

Pharmaceuticals & Biotechnology Industry and Medical Devices

for the Years 2014, 2023 & 2030

JAPAN

Nanobiotechnology Market Presence – Strong/Active/Niche/Trivial –

Key Competitors in Japan for 2023 (E)

Table 17: Japan Recent Past, Current & Future Analysis for

Nanobiotechnology by End-Use – Pharmaceuticals & Biotechnology

Industry and Medical Devices – Independent Analysis of Annual

Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 18: Japan Historic Review for Nanobiotechnology by

End-Use – Pharmaceuticals & Biotechnology Industry and Medical

Devices Markets – Independent Analysis of Annual Sales in US$

Million for Years 2014 through 2021 and % CAGR

Table 19: Japan 16-Year Perspective for Nanobiotechnology by

End-Use – Percentage Breakdown of Value Sales for

Pharmaceuticals & Biotechnology Industry and Medical Devices

for the Years 2014, 2023 & 2030

CHINA

Nanobiotechnology Market Presence – Strong/Active/Niche/Trivial –

Key Competitors in China for 2023 (E)

Table 20: China Recent Past, Current & Future Analysis for

Nanobiotechnology by End-Use – Pharmaceuticals & Biotechnology

Industry and Medical Devices – Independent Analysis of Annual

Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 21: China Historic Review for Nanobiotechnology by

End-Use – Pharmaceuticals & Biotechnology Industry and Medical

Devices Markets – Independent Analysis of Annual Sales in US$

Million for Years 2014 through 2021 and % CAGR

Table 22: China 16-Year Perspective for Nanobiotechnology by

End-Use – Percentage Breakdown of Value Sales for

Pharmaceuticals & Biotechnology Industry and Medical Devices

for the Years 2014, 2023 & 2030

EUROPE

Nanobiotechnology Market Presence – Strong/Active/Niche/Trivial –

Key Competitors in Europe for 2023 (E)

Table 23: Europe Recent Past, Current & Future Analysis for

Nanobiotechnology by Geographic Region – France, Germany,

Italy, UK and Rest of Europe Markets – Independent Analysis of

Annual Sales in US$ Million for Years 2022 through 2030 and %

CAGR

Table 24: Europe Historic Review for Nanobiotechnology by

Geographic Region – France, Germany, Italy, UK and Rest of

Europe Markets – Independent Analysis of Annual Sales in US$

Million for Years 2014 through 2021 and % CAGR

Table 25: Europe 16-Year Perspective for Nanobiotechnology by

Geographic Region – Percentage Breakdown of Value Sales for

France, Germany, Italy, UK and Rest of Europe Markets for Years

2014, 2023 & 2030

Table 26: Europe Recent Past, Current & Future Analysis for

Nanobiotechnology by End-Use – Pharmaceuticals & Biotechnology

Industry and Medical Devices – Independent Analysis of Annual

Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 27: Europe Historic Review for Nanobiotechnology by

End-Use – Pharmaceuticals & Biotechnology Industry and Medical

Devices Markets – Independent Analysis of Annual Sales in US$

Million for Years 2014 through 2021 and % CAGR

Table 28: Europe 16-Year Perspective for Nanobiotechnology by

End-Use – Percentage Breakdown of Value Sales for

Pharmaceuticals & Biotechnology Industry and Medical Devices

for the Years 2014, 2023 & 2030

FRANCE

Nanobiotechnology Market Presence – Strong/Active/Niche/Trivial –

Key Competitors in France for 2023 (E)

Table 29: France Recent Past, Current & Future Analysis for

Nanobiotechnology by End-Use – Pharmaceuticals & Biotechnology

Industry and Medical Devices – Independent Analysis of Annual

Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 30: France Historic Review for Nanobiotechnology by

End-Use – Pharmaceuticals & Biotechnology Industry and Medical

Devices Markets – Independent Analysis of Annual Sales in US$

Million for Years 2014 through 2021 and % CAGR

Table 31: France 16-Year Perspective for Nanobiotechnology by

End-Use – Percentage Breakdown of Value Sales for

Pharmaceuticals & Biotechnology Industry and Medical Devices

for the Years 2014, 2023 & 2030

GERMANY

Nanobiotechnology Market Presence – Strong/Active/Niche/Trivial –

Key Competitors in Germany for 2023 (E)

Table 32: Germany Recent Past, Current & Future Analysis for

Nanobiotechnology by End-Use – Pharmaceuticals & Biotechnology

Industry and Medical Devices – Independent Analysis of Annual

Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 33: Germany Historic Review for Nanobiotechnology by

End-Use – Pharmaceuticals & Biotechnology Industry and Medical

Devices Markets – Independent Analysis of Annual Sales in US$

Million for Years 2014 through 2021 and % CAGR

Table 34: Germany 16-Year Perspective for Nanobiotechnology by

End-Use – Percentage Breakdown of Value Sales for

Pharmaceuticals & Biotechnology Industry and Medical Devices

for the Years 2014, 2023 & 2030

ITALY

Table 35: Italy Recent Past, Current & Future Analysis for

Nanobiotechnology by End-Use – Pharmaceuticals & Biotechnology

Industry and Medical Devices – Independent Analysis of Annual

Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 36: Italy Historic Review for Nanobiotechnology by

End-Use – Pharmaceuticals & Biotechnology Industry and Medical

Devices Markets – Independent Analysis of Annual Sales in US$

Million for Years 2014 through 2021 and % CAGR

Table 37: Italy 16-Year Perspective for Nanobiotechnology by

End-Use – Percentage Breakdown of Value Sales for

Pharmaceuticals & Biotechnology Industry and Medical Devices

for the Years 2014, 2023 & 2030

UNITED KINGDOM

Nanobiotechnology Market Presence – Strong/Active/Niche/Trivial –

Key Competitors in the United Kingdom for 2023 (E)

Table 38: UK Recent Past, Current & Future Analysis for

Nanobiotechnology by End-Use – Pharmaceuticals & Biotechnology

Industry and Medical Devices – Independent Analysis of Annual

Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 39: UK Historic Review for Nanobiotechnology by End-Use –

Pharmaceuticals & Biotechnology Industry and Medical Devices

Markets – Independent Analysis of Annual Sales in US$ Million

for Years 2014 through 2021 and % CAGR

Table 40: UK 16-Year Perspective for Nanobiotechnology by

End-Use – Percentage Breakdown of Value Sales for

Pharmaceuticals & Biotechnology Industry and Medical Devices

for the Years 2014, 2023 & 2030

REST OF EUROPE

Table 41: Rest of Europe Recent Past, Current & Future Analysis

for Nanobiotechnology by End-Use – Pharmaceuticals &

Biotechnology Industry and Medical Devices – Independent

Analysis of Annual Sales in US$ Million for the Years 2022

through 2030 and % CAGR

Table 42: Rest of Europe Historic Review for Nanobiotechnology

by End-Use – Pharmaceuticals & Biotechnology Industry and

Medical Devices Markets – Independent Analysis of Annual Sales

in US$ Million for Years 2014 through 2021 and % CAGR

Table 43: Rest of Europe 16-Year Perspective for

Nanobiotechnology by End-Use – Percentage Breakdown of Value

Sales for Pharmaceuticals & Biotechnology Industry and Medical

Devices for the Years 2014, 2023 & 2030

ASIA-PACIFIC

Nanobiotechnology Market Presence – Strong/Active/Niche/Trivial –

Key Competitors in Asia-Pacific for 2023 (E)

Table 44: Asia-Pacific Recent Past, Current & Future Analysis

for Nanobiotechnology by End-Use – Pharmaceuticals &

Biotechnology Industry and Medical Devices – Independent

Analysis of Annual Sales in US$ Million for the Years 2022

through 2030 and % CAGR

Table 45: Asia-Pacific Historic Review for Nanobiotechnology by

End-Use – Pharmaceuticals & Biotechnology Industry and Medical

Devices Markets – Independent Analysis of Annual Sales in US$

Million for Years 2014 through 2021 and % CAGR

Table 46: Asia-Pacific 16-Year Perspective for

Nanobiotechnology by End-Use – Percentage Breakdown of Value

Sales for Pharmaceuticals & Biotechnology Industry and Medical

Devices for the Years 2014, 2023 & 2030

REST OF WORLD

Table 47: Rest of World Recent Past, Current & Future Analysis

for Nanobiotechnology by End-Use – Pharmaceuticals &

Biotechnology Industry and Medical Devices – Independent

Analysis of Annual Sales in US$ Million for the Years 2022

through 2030 and % CAGR

Table 48: Rest of World Historic Review for Nanobiotechnology

by End-Use – Pharmaceuticals & Biotechnology Industry and

Medical Devices Markets – Independent Analysis of Annual Sales

in US$ Million for Years 2014 through 2021 and % CAGR

Table 49: Rest of World 16-Year Perspective for

Nanobiotechnology by End-Use – Percentage Breakdown of Value

Sales for Pharmaceuticals & Biotechnology Industry and Medical

Devices for the Years 2014, 2023 & 2030

IV. COMPETITION

Read the full report: https://www.reportlinker.com/p04707106/?utm_source=PRN

About Reportlinker

ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

Contact Clare: [email protected]

US: (339)-368-6001

Intl: +1 339-368-6001

SOURCE Reportlinker

Originally published at https://www.prnewswire.com/news-releases/global-nanobiotechnology-market-to-reach-160-3-billion-by-2030–301768136.html

Part of VUGA

Part of VUGA

best company for press release distribution